These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28977823)

  • 1. Intraductal cisplatin treatment in a
    de Groot JS; van Diest PJ; van Amersfoort M; Vlug EJ; Pan X; Ter Hoeve ND; Rosing H; Beijnen JH; Youssef SA; de Bruin A; Jonkers J; van der Wall E; Derksen PWB
    Oncotarget; 2017 Sep; 8(37):60750-60763. PubMed ID: 28977823
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer treatment in mutation carriers: surgical treatment.
    Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
    Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
    Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
    Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal tree ablation by local delivery of ethanol prevents tumor formation in an aggressive mouse model of breast cancer.
    Kenyon E; Westerhuis JJ; Volk M; Hix J; Chakravarty S; Claucherty E; Zaluzec E; Ramsey L; Madaj Z; Hostetter G; Eagleson B; Shapiro E; Moore A; Sempere LF
    Breast Cancer Res; 2019 Nov; 21(1):129. PubMed ID: 31779648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
    Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC
    Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total skin-sparing mastectomy in BRCA mutation carriers.
    Peled AW; Irwin CS; Hwang ES; Ewing CA; Alvarado M; Esserman LJ
    Ann Surg Oncol; 2014 Jan; 21(1):37-41. PubMed ID: 23982256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
    N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
    Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
    BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance.
    Manning AT; Wood C; Eaton A; Stempel M; Capko D; Pusic A; Morrow M; Sacchini V
    Br J Surg; 2015 Oct; 102(11):1354-9. PubMed ID: 26313374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers.
    Lee YJ; Lee SW; Kim KR; Jung KH; Lee JW; Kim YM
    J Gynecol Oncol; 2017 Jan; 28(1):e3. PubMed ID: 27670257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.
    Cibula D; Zikan M; Dusek L; Majek O
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1197-207. PubMed ID: 21916573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.
    Schrauder MG; Brunel-Geuder L; Häberle L; Wunderle M; Hoyer J; Reis A; Schulz-Wendtland R; Beckmann MW; Lux MP
    Breast; 2017 Apr; 32():186-191. PubMed ID: 28214786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival.
    Gan A; Green AR; Nolan CC; Martin S; Deen S
    Hum Pathol; 2013 Aug; 44(8):1638-47. PubMed ID: 23574784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
    Fatouros M; Baltoyiannis G; Roukos DH
    Ann Surg Oncol; 2008 Jan; 15(1):21-33. PubMed ID: 17940826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapy options in BRCA mutation-associated breast cancer.
    Bayraktar S; Glück S
    Breast Cancer Res Treat; 2012 Sep; 135(2):355-66. PubMed ID: 22791366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.
    Evers B; Drost R; Schut E; de Bruin M; van der Burg E; Derksen PW; Holstege H; Liu X; van Drunen E; Beverloo HB; Smith GC; Martin NM; Lau A; O'Connor MJ; Jonkers J
    Clin Cancer Res; 2008 Jun; 14(12):3916-25. PubMed ID: 18559613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical prevention of breast carcinoma in patients with hereditary risk].
    Dražan L; Veselý J; Hýža P; Kubek T; Foretová L; Coufal O
    Klin Onkol; 2012; 25 Suppl():S78-83. PubMed ID: 22920212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer in BRCA mutation carriers: medical treatment.
    Milani A; Geuna E; Zucchini G; Aversa C; Martinello R; Montemurro F
    Minerva Ginecol; 2016 Oct; 68(5):557-65. PubMed ID: 26799758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.